4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide

C34H42N2O8 — CID 89175086

IUPAC4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide
SMILESCO[C@H]1C[C@H](C)CC2=C(NC(=O)c3ccc(O)cc3)C(=O)C=C(NC(=O)/C(C)=C/C=C\[C@H](OC)C/C(C)=C/[C@H](C)[C@H]1O)C2=O
InChIInChI=1S/C34H42N2O8/c1-19-14-22(4)31(39)29(44-6)17-20(2)16-26-30(36-34(42)23-10-12-24(37)13-11-23)28(38)18-27(32(26)40)35-33(41)21(3)8-7-9-25(15-19)43-5/h7-14,18,20,22,25,29,31,37,39H,15-17H2,1-6H3,(H,35,41)(H,36,42)/b9-7-,19-14+,21-8+/t20-,22+,25+,29+,31-/m1/s1
InChIKeyVITFNPROWUOSHZ-QOQCBYMQSA-N
MW606.72 g/mol
LogP3.82
Rot. Bonds4

About 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide

4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide (PubChem CID 89175086) has the molecular formula C34H42N2O8 and a molecular weight of 606.72 g/mol. Its IUPAC name is 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide.

Molecular Properties

Compound Name4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide
PubChem CID89175086
Molecular FormulaC34H42N2O8
Molecular Weight606.72 g/mol
Exact Mass606.29
IUPAC Name4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide
SMILESCO[C@H]1C[C@H](C)CC2=C(NC(=O)c3ccc(O)cc3)C(=O)C=C(NC(=O)/C(C)=C/C=C\[C@H](OC)C/C(C)=C/[C@H](C)[C@H]1O)C2=O
InChIInChI=1S/C34H42N2O8/c1-19-14-22(4)31(39)29(44-6)17-20(2)16-26-30(36-34(42)23-10-12-24(37)13-11-23)28(38)18-27(32(26)40)35-33(41)21(3)8-7-9-25(15-19)43-5/h7-14,18,20,22,25,29,31,37,39H,15-17H2,1-6H3,(H,35,41)(H,36,42)/b9-7-,19-14+,21-8+/t20-,22+,25+,29+,31-/m1/s1
InChIKeyVITFNPROWUOSHZ-QOQCBYMQSA-N
XLogP3.82
TPSA151.26 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms44
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500606.72
LogP ≤ 53.82
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}, {'alert_name': 'chinone_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide?
The IUPAC name of 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide (CID 89175086) is 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide.
What is the SMILES notation for 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide?
The canonical SMILES for 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide is CO[C@H]1C[C@H](C)CC2=C(NC(=O)c3ccc(O)cc3)C(=O)C=C(NC(=O)/C(C)=C/C=C\[C@H](OC)C/C(C)=C/[C@H](C)[C@H]1O)C2=O.
What is the InChIKey of 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide?
The InChIKey is VITFNPROWUOSHZ-QOQCBYMQSA-N. The full InChI is InChI=1S/C34H42N2O8/c1-19-14-22(4)31(39)29(44-6)17-20(2)16-26-30(36-34(42)23-10-12-24(37)13-11-23)28(38)18-27(32(26)40)35-33(41)21(3)8-7-9-25(15-19)43-5/h7-14,18,20,22,25,29,31,37,39H,15-17H2,1-6H3,(H,35,41)(H,36,42)/b9-7-,19-14+,21-8+/t20-,22+,25+,29+,31-/m1/s1.
What are the key properties of 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide?
4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide has a molecular weight of 606.72 g/mol, XLogP of 3.82, 4 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-hydroxy-N-[(4E,6Z,8R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]benzamide is sourced from PubChem (CID 89175086), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).